Therefore, the gene expression levels of four genes, HIF1A, MTHFD1, GGH and TYMS, in tumor tissues before CRT may be useful for predicting the efficacy of preoperative CRT including S-1 or UFT/LV in patients with rectal cancer. The gene discussed is MTHFD1; the disease is rectal cancer.